Science Explorer Interactive view Map
Company · Munich · Germany

Vifor Pharma (Germany)

Research works
36
▲ 7% vs 2013–17
Citations
1.4k
37.4 per fractional work
Top-10% rate
14.7%
record average 16.5%
Open access
37%
world 28%

Not ranked overall: Vifor Pharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.50× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 4.06× its world share, 0 worksImmunology and Micro…Neuroscience: 3.78× its world share, 0 worksNeuroscienceComputer Science: 0.53× its world share, 0 worksComputer ScienceEnvironmental Science: 0.16× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.33× its world share, 0 worksMaterials ScienceHealth Professions: 4.96× its world share, 0 worksHealth ProfessionsMedicine: 3.34× its world share, 3 worksMedicineDecision Sciences: 0.85× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.38× its world share, 0 worksEconomics, Econometr…Psychology: 0.67× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Health Professions, 5.0×. Every wedge is a field page.

Which keywords describe research at Vifor Pharma (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Anemia, Iron Deficiency, Inflammation, Heart Failure, Chronic Kidney Disease, Oxidative Stress, Cardiovascular Disease and Hepcidin.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Anemia6▲ 134×4 topics
  2. Inflammation5▲ 6.3×12 topics
  3. Iron Deficiency5▲ 262×2 topics
  4. Heart Failure4▲ 26×4 topics
  5. Oxidative Stress4▲ 6.5×7 topics
  6. Chronic Kidney Disease4▲ 45×5 topics
  7. Epidemiology4▲ 2.8×15 topics
  8. Cardiovascular Disease4▲ 9.7×8 topics
  9. Hepcidin3▲ 207×1 topic
  10. Iron Regulation3▲ 207×1 topic
  11. Immunotherapy2▲ 10×5 topics
  12. Neuroprotection2▲ 18×3 topics
  13. Cancer Treatment2▲ 24×2 topics
  14. Erythropoiesis-Stimulating Agents2▲ 422×1 topic
  15. Hypoxia-Inducible Factors2▲ 422×1 topic
  16. Glycosylation2▲ 24×2 topics
  17. Treatment2▲ 3.7×7 topics
  18. Fc Receptors2▲ 43×1 topic
  19. Therapeutic Antibodies2▲ 34×1 topic
  20. Diagnosis1▲ 3.7×4 topics
  21. Immune Response1▲ 6.1×4 topics
  22. Gene Therapy1▲ 13×3 topics
  23. Ion Channels1▲ 16×2 topics
  24. Pulmonary Hypertension1▲ 22×2 topics
  25. Tumor Suppression1▲ 32×2 topics
  26. Angiogenesis1▲ 8.4×2 topics
  27. Hyperkalemia1▲ 234×1 topic
  28. Metastasis1▲ 10×2 topics
  29. Renin-Angiotensin-Aldosterone System Inhibitors1▲ 234×1 topic
  30. Sickle-cell Disease1▲ 70×1 topic
  31. Thalassemia1▲ 70×1 topic
  32. Tumor Microenvironment1▲ 9.4×2 topics
  33. Tumor Regression1▲ 39×2 topics
  34. Bacterial Therapy1▲ 67×1 topic
  35. Tumor Targeting1▲ 22×1 topic
  36. Cancer1▲ 2.0×8 topics

Which research topics does Vifor Pharma (Germany) publish most on?

By volume in 2022–2025: Renal Diseases and Glomerulopathies, Health and Medical Studies, Platelet Disorders and Treatments and Chronic Kidney Disease and Diabetes.

  1. 1 Renal Diseases and Glomerulopathies Nephrology 1 works
  2. 2 Health and Medical Studies General Health Professions 0 works
  3. 3 Platelet Disorders and Treatments Hematology 0 works
  4. 4 Chronic Kidney Disease and Diabetes Nephrology 0 works
  5. 5 Myasthenia Gravis and Thymoma Neurology 0 works
  6. 6 Dermatology and Skin Diseases Dermatology 0 works
  7. 7 Medical Practices and Rehabilitation Physical Therapy, Sports Therapy and Rehabilitation 0 works
  8. 8 Complement system in diseases Immunology 0 works
  9. 9 Medical and Health Sciences Research Public Health, Environmental and Occupational Health 0 works
  10. 10 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.9%not open63.1%

World: 28% of research is openly available.

with international co-authors33.0%domestic only67.0%

World: 19% is written across borders.

How has Vifor Pharma (Germany)'s research output changed?

Output in 2018–2022 was 7% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Munich

All research institutions in Munich

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.